Markers Of Dna Copy Number Alteration For Improved Prognostication In Prostate Cancer

Abstract

The invention describes DNA copy number alterations (CNAs), identifiable by technologies such as array-based comparative genomic hybridization (array CGH) or fluorescence in situ hybridization (FISH), that define distinct genetic subtypes of prostate cancer, and are useful for improved prognostication and treatment stratification for patients with prostate cancer.


Claims
Download PDF
Document Preview
Document History
  • Publication: Dec 29, 2009
  • Application: May 12, 2006
    US US 43384406 A
  • Priority: May 12, 2006
    US US 43384406 A
  • Priority: May 13, 2005
    US US 68107305 P

Download Citation


Sign in to the Lens

Feedback